Arterium presents a new antibiotic

In the fourth quarter of 2020, a new antibacterial drug under the trade name 3-Dinir has been launched in the Ukrainian market. This third generation oral cephalosporins containing the active substance cefdinir is new to the country. The Arterium Corporation was the first to bring this molecule, which has already established itself well both in the United States and European countries, to Ukraine. 3-Dinir is used to treat a number of bacterial infections of the upper and lower respiratory tract, such as sinusitis, tonsillitis, exacerbation of chronic bronchitis, community-acquired pneumonia as well as skin and soft tissue infections. “Nowadays, the problem of developing resistance to antibiotics is becoming especially pertinent around the world. This is why bringing this new molecule to Ukraine provides a new opportunity for the effective treatment of patients with bacterial infections,” says Product Development Manager Tatiana Zagra. The drug is available in capsule form.